Cytological aspects of uterine cervical adenocarcinoma, adenosquamous carcinoma and combined adenocarcinoma-squamous carcinoma: Appraisal of diagnostic criteria for in situ versus invasive lesions

Cytopathology

Volumn 8, Issue 6, 1997, Pages 397-408

  Hayes, M M M ^a   Matisic, J P ^a   Chen, C J ^b   Mohamed, A ^a   Anderson, G H ^a   Leriche, J C ^a   Amy, R ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adenosquamous carcinoma; Cervical cytology; Cervix neoplasms; Endocervical adenocarcinoma; Screening cytology

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CARCINOMA IN SITU; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0031460210     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2303.1997.tb00570.x     Document Type: Article

References (55)

1. Draper GJ, Cook GA. Changing patterns of cervical cancer rates. Br Med J 1983; 287: 510-2.
2. Guzick DS. Efficacy of screening for cervical cancer: a review. Am J Public Health 1978; 68: 125-34.
3. Laara K, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987; i: 1247-9.
4. Macgregor JE, Moss SM, Parkin MD, Day NE. A case control study of cervical cancer screening in northeast Scotland. Br Med J 1985; 290: 1543-6.
5. Cramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical carcinoma. Cancer 1974; 34: 2018-27.
6. U.S. Center for Disease Control, National Institutes of Health. MMWR 1989; 38: 650.
7. Anderson GH, Boyes DA, Benedet JL et al. Organisation and results of the cervical cytology screening programme in British Columbia. 1955-1985. Brit Med J 1988; 296: 975-8.
8. Anderson GH, Benedet JL, LeRiche JC, Matisic JP, Thompson JE. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-188. Obstet Gynecol 1992; 80: 1-4.
9. Menezner J, Modan B, Oelsner G et al. Adenocarcinoma of the uterine cervix in Jewish women: a distinct epidemiological entity. Cancer 1978; 41: 2464-7.
10. Peters RK, Chao A, Mack TM et al. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986; 76: 423-8.
11. Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemol 1986; 124: 1054-7.
12. Young RH, Scully RE. Invasive adenocarcinoma and related tumours of the uterine cervix. Semin Diagn Pathol 1990; 7: 205-27.
13. Lawrence WD. Advances in the pathology of the uterine cervix. Hum Pathol 1991; 22: 792-806.
14. Boon ME, Baak JPA, Kurver PJH, Overdiep SH, Verdonk GE. Adenocarcinoma-in-situ of the cervix: an underdiagnosed lesion. Cancer 1981; 48: 768-73.
15. Anderson GH. Cervical cytology. In: Miller, AB ed. Screening for Cancer. New York: Academic Press, 1985: 87-103.
16. Reagan JW, Patten SF. Analytical study of cellular changes in carcinoma in situ, squamous cell cancer and adenocarcinoma of the uterine cervix. Clin Obstet Gynecol 1961; 4: 1097-127.
17. Pacey F, Ayer B, Greenberg M. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions: III. Pitfalls in diagnosis. Acta Cytol 19; 32: 325-30.
18. Reagan JW, Ng APB. The cells of uterine adenocarcinoma. In: Wied GL, ed. Monographs in Clinical Cytology, Vol.1, 2nd edn. Basel: S. Karger, 1973: 96-112.
19. Wells M, Brown LJR. Glandular lesions of the uterine cervix: the present state of our knowledge. Histopathology 1986; 10: 777-92.
20. Boon ME, de Graaff Guilloud JC, Rietveld WJ. Analysis of five sampling methods for the preparation of cervical smears. Acta Cytol 1988; 33: 843-8.
21. Kristensen GB, Holund B, Grinsted P. Efficacy of the cytobrush vs the cotton swab in collection of endocervical cells. Acta Cytol 1989; 33: 849-51.
22. Noda K, Kimura K, Ikelda M, Teshima K. Studies on the pathogenesis of cervical adenocarcinoma. Int J Gynecol Pathol 1983; 1: 336-46.
23. Tase T, Okagaki T, Clark BA et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix and coexisting squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989; 8: 8-17.
24. Alejo M, Macedo I, Matias-Guiu X, Prat J. Adenocarcinoma in situ of the uterine cervix: clinicopathological study of nine cases with detection of human papilloma virus DNA by in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1993; 12: 219-23.
25. Brown LJR, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion?. J Clin Pathol 1986; 39: 22-28.
26. Steiner G, Friedell GH. Adenosquamous carcinoma in situ of the cervix. Cancer 1965; 18: 807-10.
27. Qizilbash A. In situ and microinvasive adenocarcinoma of the uterine cervix. Am J Clin Pathol 1975; 64: 155-70.
28. Jaworski RC, Pacey NF, Greenberg ML, Osborn RA. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Adenocarcinoma in situ. Cancer 1988; 61: 1171-81.
29. Ayer B, Pacey F, Greenberg M. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions:II. Microinvasive adenocarcinoma. Acta Cytol 1988; 32: 318-24.
30. Christopherson WM, Nealon N, Gray LA. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979: 44: 975-83.
31. Ostor AG, Pagano R, Davoren RAM et al. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984; 3: 179-90.
32. Atanasoff P, Goff B, Brown E et al. The significance of endocervical glandular atypia in cervicovaginal smears. Acta Cytol 1991; 35: 592-3.
33. Jaworski RG. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol 1990; 7: 190-204.
34. Rombaut RP, Charles D, Murphy A. Adenocarcinoma of the cervix. A clinico-pathologic study of 47 cases. Cancer 1966; 19: 891-900.
35. Young RH, Clement PB, Scully RE. Premalignant and malignant glandular lesions of the uterine cervix. In: Clement Young, eds. Contemporary Issues in Pathology, Edinburgh: Churchill Livingston: 1993.
36. Tobon H, Dave H. Adenocarcinoma in situ of the cervix: Clinicopathological observations of 11 cases. Int J Gynecol Pathol 1988; 7: 139-51.
37. Kaminski PF, Norris HJ. Minimal deviation carcinoma (adenoma malignum) of the cervix. Int J Gynecol Pathol 1983; 2: 141-52.
38. Szyfelbein WM, Young RH, Scully RE. Adenoma malignum of the cervix: cytologic findings. Acta Cytol 1983; 28: 691-8.
39. Jones MW, Silverberg SG, Kurman RJ. Adenoma malignum of the cervix: cytologic findings. Int J Gynecol Pathol 1993; 12: 1-7.
40. Young RH, Scully RE. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinico-pathologic analysis of 13 cases. Cancer 1989; 63: 1773-9.
41. Friedell GH, McKay DG. Adenocarcinoma-in situ of the endocervix. Cancer 1953; 6: 887-97.
42. Weisbrot IM, Stabinsky C, Davis AM. Adenocarcinoma in situ of the uterine cervix. Cancer 1972; 29: 1179-87.
43. Rhode D. Zytologie des adenocarcinoma in situ der Cervix uteri. Geburtshilfe Frauenheilkd 1982; 42: 609-12.
44. Barter RA, Waters ED. Cyto- and histo-morphology of cervical adenocarcinoma in situ. Pathology 1970; 2: 33-40.
45. Krumins I, Young Q, Pacey F, Bousfield L, Mulhearn L. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri. Acta Cytol 1977; 21: 320-9.
46. Bousfield L, Pacey F, Young Q, Krumin I, Osborn R. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. Acta Cytol 1980; 24: 283-96.
47. Fiorella RM, Casafrancisco D, Yokota S, Kragel PJ. Artifactual endocervical atypia induced by endocervical brush collection. Diagn Cytopathol 1994; 11: 79-84.
48. Ayer B, Pacey F, Greenberg M, Bousfield L. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions: I. Adenocarcinoma in situ. Acta Cytol 1987; 37: 397-411.
49. Lee KR, Manna EA, Jones MA. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix. Acta Cytol 1991; 35: 117-26.
50. Rollason TP, Cullimore J, Bradgate MG. A suggested columnar cell morphological equivalent of squamous carcinoma in situ with early stromal invasion. In J Gynecol Pathol 1989; 8: 230-6.
51. Keyani-Rofagha S, Brewer J, Prokorym P. Comparative cytologic findings of in situ and invasive adenocarcinoma of the uterine cervix. Diagn Cytopathol 1995; 12: 120-5.
52. Ng WF, Choi FB, Cheung LL, Wu C, Leung CF, Ng CS. Rehydration of air-dried smears with normal saline: application in fluid cytology. Acta Cytol 1994; 38: 56-64.
53. Ngyyen GK, Jeannot AB. Exfoliative cytology of in situ and microinvasive adenocarcinoma of the uterine cervix. Acta Cytol 1984; 28: 461-7.
54. Betsill WL, Clark AH. Early endocervical glandular neoplasia:I. Histomorphology and cytomorphology. Acta Cytol 1986; 30: 115-26.
55. Clarke AH, Betsill WL. Early endocervical glandular neoplasia. II. Morphomeric analysis of the cells. Acta Cytol 1986; 30: 127-33.